Showing results (101-110 of 126) with videos related to
Sort By:
Pageof 13
ACS Nano|April 14, 2023
Confined Cascade Metabolic Reprogramming Nanoreactor for Targeted Alcohol Detoxification and Alcoholic Liver Injury ManagementXudong Geng, Xuancheng Du, Weijie Wang, et al.Oncotarget|March 19, 2016
Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinomaZhikui Liu, Changwei Dou, Bowen Yao, et al.Journal of Nanobiotechnology|January 19, 2023
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel diseaseYameng Cao, Kai Cheng, Mei Yang, et al.Cell Death & Disease|February 7, 2020
LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cellsLiankang Sun, Liang Wang, Tianxiang Chen, et al.Journal of Nanobiotechnology|December 22, 2023
Carbon dot nanozymes as free radicals scavengers for the management of hepatic ischemia-reperfusion injury by regulating the liver inflammatory network and inhibiting apoptosisHaoge Geng, Jiayu Chen, Kangsheng Tu, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|June 6, 2024
FAM188B promotes the growth, metastasis, and invasion of hepatocellular carcinoma by targeting the hnRNPA1/PKM2 axisMingshan Mu, Yisong Lu, Kangsheng Tu, et al.Journal of Cancer|March 23, 2026
FAM188B promotes progression of hepatocellular carcinoma by regulating YAP/TAZ via interaction with USP10Siwei Hu, Yuting Wen, Yihong Chen, et al.Theranostics|June 3, 2020
CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathwayNan Yang, Tianxiang Chen, Liang Wang, et al.Journal of Experimental & Clinical Cancer Research : CR|April 20, 2019
Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMPLiankang Sun, Yufeng Wang, Liang Wang, et al.Oncotarget|May 19, 2016
Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinomaZhikui Liu, Changwei Dou, Bowen Yao, et al.Pageof 13